SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: Cybersecurity, Internet of Things (IoT), and Licensing and Other. The Cybersecurity segment includes the brand Cylance, BlackBerry Spark, AtHoc, and SecuSUITE. The IoT segment focuses on software licenses, support, maintenance, and professional services. The Licensing and Other segment involves the intellectual property licensing arrangements and settlement awards. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending as investors react to a significant expansion of its partnership with Nvidia, which integrates the QNX operating system into safety-critical edge AI platforms for robotics and industrial applications. The community is actively discussing this as a potential fundamental inflection point, moving beyond the stock's previous meme-status reputation toward a narrative focused on its essential role in the emerging physical AI and software-defined vehicle sectors.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is experiencing high volatility as investors weigh strong quarterly earnings and aggressive share buybacks against cautious forward guidance and the departure of a long-standing board member. The community remains deeply divided, with many retail traders actively buying the dip, while others express concerns over institutional selling pressure and potential downside risks.

Newcourt Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 25, 2021 and is headquartered in Oakland, CA.

Psyence Biomedical Ltd.

Psyence Biomedical is experiencing high volatility and retail interest driven by an executive order to fast-track psychedelic research, which market participants view as a significant catalyst for ibogaine-based treatments. The community is actively debating the stock's potential for a massive short squeeze given its exceptionally low float, while cautious traders warn of the risks associated with micro-cap volatility and the potential for aggressive dilution.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth is currently trending amid a significant strategic shift as the company acquires Brazil's Serra Verde Group in a transaction aimed at securing a non-Asian source for key magnetic rare earth elements. While investors and market analysts are actively debating the potential for long-term supply chain dominance and government-backed infrastructure status, the stock is seeing heightened volatility due to concerns over share dilution and the aggressive positioning of short sellers.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf is trending as investors react to a large upsized stock offering intended to fuel data center expansion and debt repayment, fueling community debate over the impact of dilution versus the company's long-term growth potential in AI infrastructure. Despite the share issuance, bullish sentiment remains strong as traders highlight the firm's strategic focus on securing power for hyperscale data centers and anticipate upcoming announcements regarding lease agreements in Kentucky.

Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

Fermi LLC is facing significant volatility and intense community scrutiny following a sudden leadership shakeup where both the CEO and CFO departed, fueling concerns over transparency and governance. Investors are actively debating whether this transition, paired with the ongoing search for a major anchor tenant for the Matador data center project, represents a structural breakdown or a strategic pivot toward professionalizing the company for future growth.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is currently garnering significant attention as retail and institutional investors alike speculate on a potential buyout or major partnership, driven by excitement over the firm's oncology pipeline and positive clinical trial data. Community sentiment is highly polarized, with optimistic long-term holders highlighting upcoming trial milestones and regulatory progress, while vocal skeptics point to the stock's long-term performance and historical dilution as reasons for caution.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is rallying following a strategic announcement to redomicile in the U.S. and resolve tax-related concerns, effectively neutralizing a recent short-seller report. The community is actively debating the stock's potential for a short squeeze and long-term valuation shifts as investors shift focus toward upcoming commercial manufacturing milestones and institutional accumulation.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group is facing intense downward pressure and hitting record lows as investors react to continued share dilution and skepticism surrounding the companys path to profitability. The community remains deeply divided, with some traders betting on a potential short squeeze or buyout, while many others are expressing frustration over management's performance and the stock's persistent freefall.

Atai Beckley, Inc. is a clinical-stage biopharmaceutical company focused on developing effective, rapid-acting, and convenient mental health treatments. The company is headquartered in New York, NY.

AtaiBeckley Inc.

ATAI is trending as the market reacts to an executive order aimed at fast-tracking psychedelic drug research for veterans and mental health, fueling speculation about clinical acceleration and potential pharmaceutical partnerships for the company's BPL-003 candidate. Community sentiment is divided between optimism regarding recent pipeline milestones and clinical validation versus frustration over historical share dilution and persistent intraday price weakness.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CDXS $NVS $RNA Falls nicely in hand with their latest venture, Atrium Therapeutics and &quot;will focus on precision RNA therapeutics for rare, genetic cardiomyopathies.&quot;  https://www.pharmavoice.com/news/novartis-avidity-atrium-spinoff-rna-heart/815050/

alleyes onme

$CDXS I&#39;ve said this before and I will say it again, the only thing IMHO opinion for investing all this money into the ECO Synthesis GMP production facility they are building out in Hayward is if they have a &#39;very large potential contract&#39; to manufacture on the line.  What would that be?  Inclisiran.  It is currently solely produced in Europe by $NVS .  What did Jimenez clearly say yesterday, &quot;scale from 100 grams to 0.5 kilograms by year end...supported by successful quality inspections by a large pharmaceutical customer.&quot;   
 
That being said:  &quot;We expect to be in a position by middle of this year where we are not really exposed to tariffs, because we’re able to produce in the U.S. for the U.S. We have inventory on hand,&quot; Narasimhan told CNBC.&quot; 
 
 
https://www.investing.com/news/stock-market-news/novartis-ceo-says-company-likely-shielded-from-us-tariffs-93CH-4454980

Novartis CEO says company likely shielded from U.S. tariffs

Novartis CEO says company likely shielded from U.S. tariffs By Investing.com

StockTwits Web

Codexis Inc.

Novartis AG

Bobby McBean

$CDXS $NVS $RNA  
And lines up nicely with an &#39;unnamed company&#39; in their latest PR .   
 
&quot;This agreement allows Codexis to supply siRNA material to support its partner’s preclinical program targeting a cardiovascular indication. Successfully delivering 50 grams marks an inflection point—more than tenfold typical research volumes—signaling Codexis’s capability to meet more demanding supply needs as RNA therapies expand into more prevalent diseases.&quot;    
 
Just saying ;) 
 
https://marketchameleon.com/articles/b/2026/3/5/codexis-agreement-50g-sirna-eco-synthesis-platform-expansion

Atrium Therapeutics Inc.

 Falls nicely in hand with their latest venture, Atrium Therapeutics and "will focus on precision RNA therapeutics for rare, genetic cardiomyopathies."  

Alnylam Pharmaceuticals Inc

Arrowhead Pharmaceuticals Inc.

Ionis Pharmaceuticals Inc

Merck & Co Inc

Bachem Holding AG

D-Wave Quantum Inc

@Fingerlickengood bang on, 100%, you don’t sign 12m lease on new facility without assurances of significant supply, API opportunities, assurances.  11$ target may not be to “out there” , many deals close to closing, many partnerships/collaborations with giant pharma. SUPER BULLISH.

StockTwits for iOS

 bang on, 100%, you don’t sign 12m lease on new facility without assurances of significant supply, API opportunities, assurances.  11$ target may not be to “out there” , many deals close to closing, many partnerships/collaborations with giant pharma. SUPER BULLISH.